Thus, the marked correlation of RE-LYMP with IL-6 levels in our SSc patients might suggest RE-LYMP as an easily accessible, reliable indicator of systemic inflammation in systemic sclerosis. This evidence concerns the gene IL6 and systemic sclerosis.